Coya Therapeutics (NASDAQ:COYA) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.28) by 21.86 percent. This is a 88.89 percent decrease over losses of $(0.18) per share from the same period last year. The company reported quarterly sales of $3.960 million which beat the analyst consensus estimate of $1.928 million by 105.39 percent. This is a 102.87 percent increase over sales of $1.952 million the same period last year.